Pharmacological effects of carvedilol on T-type calcium current in murine HL-1 cells

European Journal of Pharmacology

Volumn 621, Issue 1-3, 2009, Pages 19-25

  Deng, Chunyu ^a,b   Rao, Fang ^a,b   Wu, Shulin ^a,b   Kuang, Sujuan ^a,b   Liu, Xiaoying ^a,b   Zhou, Zhiling ^a,b   Shan, Zhixin ^a,b   Lin, Qiuxiong ^a,b   Qian, Weimin ^a,b   Yang, Min ^a,b   Geng, Qingshan ^a,b   Zhang, Youyi ^c   Yu, Xiyong ^a,b   Lin, Shuguang ^a,b  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b Guangdong Provincial Cardiovascular Institute   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Carvedilol; HL 1 cells; T type Calcium Current (ICa,T); Whole cell patch clamp technique

Indexed keywords

CALCIUM CHANNEL T TYPE; CALCIUM ION; CARVEDILOL; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FLUORESCENT DYE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CELL MEMBRANE POTENTIAL; CHANNEL GATING; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; HEART ATRIUM; HEART MUSCLE CELL; INHIBITION KINETICS; MOUSE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; STEADY STATE; TIME;

ANIMALS; CALCIUM; CALCIUM CHANNELS, T-TYPE; CARBAZOLES; CELL LINE; ELECTRIC CONDUCTIVITY; ISOQUINOLINES; KINETICS; MICE; PATCH-CLAMP TECHNIQUES; PROPANOLAMINES; SULFONAMIDES;

EID: 70349484966     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.08.032     Document Type: Article

References (27)

1. Alvarez J.L., Rubio L.S., and Vassort G. Facilitation of T-type calcium current in bullfrog atrial cells: voltage-dependent relief of a G protein inhibitory tone. J. Physiol. 491 (1996) 321-334
2. 2+ current in rabbit ventricular myocytes. Eur. J. Pharmacol. 376 (1999) 189-201
3. Claycomb W.C., Lanson N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., and Izzo N.J. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U S A. 95 (1998) 2979-2984
4. Deng C., Yu X., Kuang S., Zhang W., Zhou Z., Zhang K., Qian W., Shan Z., Yang M., Wu S., and Lin S. Effects of carvedilol on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes. Life Sci. 80 (2007) 665-671
5. Dunn C.J., Lea A.P., and Wagstaff A.J. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 54 (1997) 161-185
6. (2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. Circulation 100 (1999) 2191-2197
7. 2+ channel during fetal and postnatal rat heart development. J. Mol. Cell Cardiol. 34 (2002) 533-546
8. Ferron L., Capuano V., Ruchon Y., Deroubaix E., Coulombe A., and Renaud J.F. Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels. Circ. Res. 93 (2003) 1241-1248
9. Furukawa T., Ito H., Nitta J., Tsujino M., Adachi S., Hiroe M., Marumo F., Sawanobori T., and Hiraoka M. Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal rat ventricular myocytes. Circ. Res. 71 (1992) 1242-1253
10. Hagiwara N., Irisawa H., and Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J. Physiol. 395 (1988) 233-253
11. Karle C.A., Kreye V.A., Thomas D., Rockl K., Kathofer S., Zhang W., and Kiehn J. Antiarrhythmic drug carvedilol inhibits HERG potassium channels. Cardiovasc. Res. 49 (2001) 361-370
12. Katritsis D.G. Carvedilol is more effective than metoprolol in preventing atrial fibrillation (AF) after coronary artery bypass. Heart Rhythm. 5 (2008) 504-505
13. Kawai K., Qin F., Shite J., Mao W., Fukuoka S., and Liang C.S. Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy. Am J. Physiol. Heart Circ. Physiol. 287 (2004) H1003-H1012
14. Kawakami K., Nagatomo T., Abe H., Kikuchi K., Takemasa H., Anson B.D., Delisle B.P., January C.T., and Nakashima Y. Comparison of HERG channel blocking effects of various beta-blockers - implication for clinical strategy. Br. J. Pharmacol. 147 (2006) 642-652
15. Kino-Oka M., Maeda Y., Yamamoto T., Sugawara K., and Taya M. A kinetic modeling of chondrocyte culture for manufacture of tissue-engineered cartilage. J. Biosci. Bioeng. 99 (2005) 197-207
16. McTavish D., Campoli-Richards D., and Sorkin E.M. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 45 (1993) 232-258
17. Ohlstein E.H., Douglas S.A., Sung C.P., Yue T.L., Louden C., Arleth A., Poste G., Ruffolo R.R., and Feuerstein G.Z. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury. Proc. Natl. Acad. Sci. U S A. 90 (1993) 6189-6193
18. Patel M.K., Chan P., Betteridge L.J., Schachter M., and Sever P.S. Inhibition of human vascular smooth muscle cell proliferation by the novel multiple-action antihypertensive agent carvedilol. J. Cardiovasc. Pharmacol. 25 (1995) 652-657
19. Schwarz E.R., Kersting P.H., Reffelmann T., Meven D.A., Al-Dashti R., Skobel E.C., Klosterhalfen B., and Hanrath P. Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart. J. Cardiovasc. Pharmacol. Ther. 8 (2003) 207-215
20. 2+ channel blocker efonidipine on cardiomyopathic hamsters. Circ. J. 71 (2007) 1970-1976
21. 2+ channels in the heart. Cell Calcium 40 (2006) 205-220
22. Villame J., Massicotte J., Jasmin G., and Dumont L. Effects of mibefradil, a T- and L-type calcium channel blocker, on cardiac remodeling in the UM-X7.1 cardiomyopathic hamster. Cardiovasc Drugs Ther. 15 (2001) 41-48
23. 2+ channels in murine HL-1 cells. J. Mol. Cell Cardiol. 36 (2004) 111-119
24. Yang Z., Shen W., Rottman J.N., Wikswo J.P., and Murray K.T. Rapid stimulation causes electrical remodeling in cultured atrial myocytes. J. Mol. Cell Cardiol. 38 (2005) 299-308
25. Yokoyama A., Sato N., Kawamura Y., Hasebe N., and Kikuchi K. Electrophysiological effects of carvedilol on rabbit heart pacemaker cells. Int Heart J. 48 (2007) 347-358
26. Yuan Z., Shioji K., Kihara Y., Takenaka H., Onozawa Y., and Kishimoto C. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H83-H90
27. Zhang L.M., Wang Z., and Nattel S. Effects of sustained beta-adrenergic stimulation on ionic currents of cultured adult guinea pig cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H880-H889